Findings indicate that cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) and intraoperative radiation therapy (IORT) significantly improves overall survival (63 months) and disease-free survival (87 months) for gastric cancer patients. Over one-third of participants experienced no postoperative complications, while those who did faced a median of just one complication, primarily grade II. The absence of in-hospital mortality underscores the treatment’s safety profile alongside its efficacy.
Journal Article by Alaswad MM, Arabi TZ (…) Amin TM et 11 al. in World J Surg Oncol
© 2025. The Author(s).